TCTM Enrolls Rosacea Study in 19 Weeks

Total Clinical Trial Management continues to maintain an outstanding track record of enrolling all studies early or on time as recruitment for a Phase III dermatology program completed 2 weeks ahead of schedule. Originally, the team planned to randomize 924 patients...

Dr. Diana Foster Presents at WAMC Barcelona

Diana Foster, Chief Executive Officer at Total Clinical Trial Management, recently presented at the World Affordable Medicine Congress (WAMC). The WAMC is one of the largest scientific events related to generic and biosimilar medicines and was held in Barcelona, Spain...